A detailed history of Endurance Wealth Management, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 400 shares of EDIT stock, worth $500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$500
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 28, 2021

SELL
$39.27 - $72.94 $3,927 - $7,294
-100 Reduced 20.0%
400 $16,000
Q2 2021

Aug 04, 2021

SELL
$31.29 - $56.64 $25,032 - $45,312
-800 Reduced 61.54%
500 $28,000
Q1 2021

May 05, 2021

BUY
$39.71 - $90.58 $3,971 - $9,058
100 Added 8.33%
1,300 $55,000
Q4 2019

Jan 14, 2020

BUY
$19.49 - $32.63 $23,387 - $39,156
1,200 New
1,200 $36,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $85.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Endurance Wealth Management, Inc. Portfolio

Follow Endurance Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.